ACTINIUM PHARMACEUTICALS INC (ATNM)

US00507W2061 - Common Stock

1.44  +0.18 (+14.29%)

After market: 1.37 -0.07 (-4.86%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
81.00K81.00K1.03M1.14M0.00
Operating Expenses
45.04M52.00M35.13M26.11M22.39M
Research and Development
33.35M38.49M22.99M17.94M16.05M
Selling, General, and Administrative Expenses
11.69M13.30M11.99M8.06M6.29M
Operating Income
-44.96M-51.92M-34.10M-24.96M-22.39M
Interest Income/Expense
4.04M3.10M1.09M190.00K178.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-40.91M-48.82M-33.02M-24.77M-22.21M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-40.91M-48.82M-33.02M-24.77M-22.22M
EBITDA
-44.15M-51.13M-33.41M-24.44M-21.95M
 
Per Share Data
EPS Diluted Total Ops
-1.40-1.83-1.37-1.20-1.83
Non GAAP EPS
-1.40-1.84-1.37-1.20-2.04
 
Statistics
Profit Margin
-50512.35%-60269.14%-3205.53%-2165.56%N/A
Operating Profit Margin
-55504.94%-64098.77%-3311.07%-2182.17%N/A

All data in USD

Charts